Strategies for the delivery of multiple collinear infusion clouds in convection-enhanced delivery in the treatment of parkinson's disease

Stereotactic and Functional Neurosurgery

Volumn 91, Issue 3, 2013, Pages 153-161

  Sillay, Karl ^a,b   Hinchman, Angelica ^a   Kumbier, Lauren ^a   Schomberg, Dominic ^a   Ross, Chris ^c   Kubota, Ken ^d   Brady, Martin ^e   Brodsky, Ethan ^b   Miranpuri, Gurwattan ^a   Raghavan, Raghu ^e  

^a University of Wisconsin Health   (United States)

^b University of Wisconsin Madison   (United States)

^c Engineering Resources Group   (United States)

^d Kinetics Foundation   (United States)

^e Departments of Therataxis   (United States)

Author keywords

Collinear infusions; Convection enhanced delivery; Gene therapy; Parkinson's disease; Restorative neurosurgery

Indexed keywords

AGAROSE;

ARTICLE; CATHETER; COLLINEAR PAYLOADS UTILIZING CONVECTION ENHANCED DELIVERY; COMPARATIVE STUDY; DRUG DELIVERY SYSTEM; INFUSION PUMP; INFUSION SYSTEM; MORPHOLOGY; NEUROSURGERY; PARKINSON DISEASE; SNFUSION CLOUD PAIR; THERMODYNAMICS;

EID: 84874263966     PISSN: 10116125     EISSN: 14230372     Source Type: Journal    
DOI: 10.1159/000345270     Document Type: Article

References (14)

1. Mandel RJ, Burger C: Clinical trials in neurological disorders using AAV vectors: promises and challenges. Curr Opin Mol Ther 2004; 6: 482-490.
2. Mehta AI, Choi BD, Ajay D, Raghavan R, Brady M, Friedman AH, Pastan I, Bigner DD, Sampson JH: Convection enhanced delivery of macromolecules for brain tumors. Curr Drug Discov Technol 2012, E-pub ahead of print.
3. Bobo RH, Laske DW, Akbasak A, Morrison PF, Dedrick RL, Oldfield EH: Convectionenhanced delivery of macromolecules in the brain. Proc Natl Acad Sci USA 1994; 91: 2076-2080.
4. Ratliff JK, Oldfield EH: Convection-enhanced delivery in intact and lesioned peripheral nerve. J Neurosurg 2001; 95: 1001-1011.
5. Raghavan R, Brady M: Predictive models for pressure-driven fluid infusions into brain parenchyma. Phys Med Biol 2011; 56: 6179-6204.
6. Bidros DS, Liu JK, Vogelbaum MA: Future of convection-enhanced delivery in the treatment of brain tumors. Future Oncol 2010; 6: 117-125.
7. LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, Kostyk SK, Thomas K, Sarkar A, Siddiqui MS, Tatter SB, Schwalb JM, Poston KL, Henderson JM, Kurlan RM, Richard IH, Van Meter L, Sapan CV, During MJ, Kaplitt MG, Feigin A: AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial. Lancet Neurol 2011; 10: 309-319.
8. Marks WJ Jr, Bartus RT, Siffert J, Davis CS, Lozano A, Boulis N, Vitek J, Stacy M, Turner D, Verhagen L, Bakay R, Watts R, Guthrie B, Jankovic J, Simpson R, Tagliati M, Alterman R, Stern M, Baltuch G, Starr PA, Larson PS, Ostrem JL, Nutt J, Kieburtz K, Kordower JH, Olanow CW: Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial. Lancet Neurol 2010; 9: 1164-1172.
9. Bartus RT, Herzog CD, Chu Y, Wilson A, Brown L, Siffert J, Johnson EM Jr, Olanow CW, Mufson EJ, Kordower JH: Bioactivity of AAV2-neurturin gene therapy (CERE-120): differences between Parkinson's disease and nonhuman primate brains. Mov Disord 2011; 26: 27-36.
10. Marks WJ Jr, Ostrem JL, Verhagen L, Starr PA, Larson PS, Bakay RA, Taylor R, Cahn-Weiner DA, Stoessl AJ, Olanow CW, Bartus RT: Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial. Lancet Neurol 2008; 7: 400-408.
11. Sillay K, Schomberg D, Hinchman A, Kumbier L, Ross C, Kubota K, Brodsky E, Miranpuri G: Benchmarking the ERG valve tip and MRI interventions smart flow neurocatheter convection-enhanced delivery system's performance in a gel model of the brain: employing infusion protocols proposed for gene therapy for Parkinson's disease. J Neural Eng 2012; 9: 026009.
12. Emborg ME, Joers V, Fisher R, Brunner K, Carter V, Ross C, Raghavan R, Brady M, Raschke J, Kubota K, Alexander A: Intraoperative intracerebral MRI-guided navigation for accurate targeting in nonhuman primates. Cell Transplant 2010; 19: 1587-1597.
13. Richardson RM, Kells AP, Rosenbluth KH, Salegio EA, Fiandaca MS, Larson PS, Starr PA, Martin AJ, Lonser RR, Federoff HJ, Forsayeth JR, Bankiewicz KS: Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson's disease. Mol Ther 2011; 19: 1048-1057.
14. Ivan ME, Martin A, Starr PA, Sootsman K, Larson PS: Brain shift analysis during burr hole based procedures using interventional MRI. J Neurosurg 2006; 104:A659.